Expert consensus on vaccination in patients with inflammatory bowel disease in Japanarticle Published on 2023-01-112024-09-02 Journal: Journal of Gastroenterology [Category] 대상포진, [키워드] Crohn’s disease immunization ulcerative colitis Vaccine-preventable disease [DOI] 10.1007/s00535-022-01953-w PMC 바로가기 [Article Type] article
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramArticle Published on 2023-01-052023-05-31 Journal: Inflammatory bowel diseases [Category] 두창, 수두, 홍역, [키워드] age clinical response Safety Tofacitinib ulcerative colitis [DOI] 10.1093/ibd/izac084 PMC 바로가기
Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving TofacitinibClinical Trial Published on 2023-01-052023-05-31 Journal: Inflammatory bowel diseases [Category] 두창, 수두, 홍역, [키워드] herpes zoster Tofacitinib ulcerative colitis [DOI] 10.1093/ibd/izac063 PMC 바로가기 [Article Type] Clinical Trial
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel DiseaseArticle Published on 2022-12-292023-07-11 Journal: Nutrients [Category] COVID19(2023년), [키워드] cholecalciferol COVID-19 Crohn’s disease IBD monoclonal antibodies SARS-CoV-2 ulcerative colitis Vitamin D [DOI] 10.3390/nu15010169 PMC 바로가기
Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel diseaseMinireviews Published on 2022-12-212024-09-04 Journal: World journal of gastroenterology [Category] 대상포진, [키워드] Clinical remission Crohn’s disease Dual-therapy biologic therapy Inflammatory bowel disease small molecule drugs ulcerative colitis [DOI] 10.3748/wjg.v28.i47.6743 PMC 바로가기 [Article Type] Minireviews
Tofacitinib in the treatment of ulcerative colitis A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)article Published on 2022-12-012024-09-02 Journal: Wiener Klinische Wochenschrift [Category] 대상포진, [키워드] Effectiveness Janus kinase inhibitor Safety Small molecules ulcerative colitis [DOI] 10.1007/s00508-022-02110-2 PMC 바로가기 [Article Type] article
A review of the therapeutic management of ulcerative colitisReview Published on 2022-11-292024-09-04 Journal: Therapeutic Advances in Gastroenterology [Category] 대상포진, [키워드] anti-TNFs biologics Corticosteroids Inflammatory bowel disease ulcerative colitis [DOI] 10.1177/17562848221138160 PMC 바로가기 [Article Type] Review
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] SARS, 진단, [키워드] adjusted age All participant anti-SARS-CoV-2 anti-TNF antibody Antibody binding antibody concentration Antibody concentrations approved available data boost booster case-control study combination therapy Concentration control group COVID-19 COVID-19 vaccine Diagnosis disease dose Evidence first dose geometric mean geometric mean ratio group groups had no healthy control healthy individuals heterologous vaccine homologous IBD Immunosuppressed immunosuppressed patient immunosuppressive Immunosuppressive treatment Infection Inflammatory bowel disease jak inhibitors multicentre multivariable nine no significant difference Older Older age participant Patient patients treated Pfizer Primary outcome receiving Receptor binding domain recipient recruited reduced regimen response S1 RBD SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccination significantly significantly lower Support T-cell Response T-cell responses the healthy therapy Tofacitinib Treatment ulcerative colitis Vaccine vaccine dose vaccine doses vaccine-induced antibody response VIP were measured [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyArticle Published on 2022-10-052022-11-15 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI analyzed anti-RBD antibodies binding antibody antibody level blood sample bowel collected combination treatment Control controls COVID-19 declined defined disease dose enrolled Factor greater healthy healthy control healthy individuals Humoral immunity identify Immune-mediated inflammatory disease immunosuppressive Immunosuppressive medication Inflammatory bowel disease inhibitor initial interval median Multivariable regression Necrosis participant Patient patients persistence prospective cohort study Protein provided psoriatic arthritis RBD reduction reduction in Rheumatic diseases rheumatoid arthritis SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine serologic Serologic response spike spondyloarthritis Support the receptor-binding domain the SARS-CoV-2 Therapies therapy ulcerative colitis vaccination vaccine dose [DOI] 10.1186/s12916-022-02587-8 PMC 바로가기
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVIDObservational Study Published on 2022-10-032023-07-07 Journal: Inflammatory bowel diseases [Category] COVID19(2023년), [키워드] COVID-19 Crohn’s disease Preventive care ulcerative colitis vaccination [DOI] 10.1093/ibd/izab302 PMC 바로가기 [Article Type] Observational Study